Predictors for Super-Responders in Cardiac Resynchronization Therapy

Am J Ther. 2024 Jan-Feb;31(1):e13-e23. doi: 10.1097/MJT.0000000000001692. Epub 2023 Jan 10.

Abstract

Background: Prediction of cardiac resynchronization therapy (CRT) response, particularly a super-response, is of great importance.

Study question: The aim of our study was to assess the predictors for super-responders in CRT.

Study design: We conducted a retrospective, observational study, which finally included 622 patients with heart failure treated with CRT between January 2008 and May 2020 who had a minimal follow-up of 6 months after CRT.

Measures and outcomes: A total of 192 super-responders, defined by a left ventricular ejection fraction (LVEF) of at least 45%, and/or minimum 15% increase in LVEF and an improvement of the New York Heart Association functional class by at least 2 degrees at the last follow-up, and the rest of 430 patients who did not fulfill the super-responder criteria.

Results: The highest rate of super-responders (41.91%, n = 171) was at patients with left ventricle-only pacing with optimal fusion (OPT) compared with patients with biventricular (BiV) pacing (9.81%, n = 21, P < 0.000). In the OPT group, univariable analysis showed that nonischemic cardiomyopathy, a smaller degree of mitral regurgitation, and better left ventricle function at enrollment were predictors for super-response compared with the BiV group where a narrower QRS after implantation, nonischemic cardiomyopathy, and a better baseline LVEF were predictors for super-responders. In the multivariable analysis, both narrower QRS after implantation and nonischemic cardiomyopathy were independent predictors for super-response in the BiV group compared with OPT where nonischemic cardiomyopathy remained the only independent predictor for super-response.

Conclusions: In this retrospective study, OPT CRT programing was an additional predictor of super-response to CRT besides nonischemic cardiomyopathy.

Publication types

  • Observational Study

MeSH terms

  • Cardiac Resynchronization Therapy*
  • Cardiomyopathies*
  • Humans
  • Retrospective Studies
  • Stroke Volume
  • Ventricular Function, Left